Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

303.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 445.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 106.00m
  • Volume: 65,572
  • Market Cap: £321.71m
  • RiskGrade: 125

Latest ShareCast News

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

OXB Regulatory News

Grant of options 16-May-2025 17:52 RNS
Total Voting Rights 01-May-2025 07:00 RNS
Person Closely Associated Dealing 30-Apr-2025 16:49 RNS
Holding(s) in Company 29-Apr-2025 18:14 RNS
2025 Annual General Meeting notification 28-Apr-2025 13:00 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 303.50p
Change Today -1.00p
% Change -0.33 %
52 Week High 445.00
52 Week Low 232.50
Volume 65,572
Shares Issued 106.00m
Market Cap £321.71m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.75% below the market average29.75% below the market average29.75% below the market average29.75% below the market average29.75% below the market average
10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average10.64% above the sector average
Price Trend
51.35% below the market average51.35% below the market average51.35% below the market average51.35% below the market average51.35% below the market average
2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average2.13% below the sector average
Income Not Available
Growth
1.80% above the market average1.80% above the market average1.80% above the market average1.80% above the market average1.80% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 22-May-2025

Time Volume / Share Price
16:35 19,685 @ 303.50p
16:35 216 @ 303.50p
16:35 253 @ 303.50p
16:35 50 @ 303.50p
16:35 36 @ 303.50p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page